Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849810 · ClinicalTrials.gov registry record · NA
Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate
A NA study, sponsored by University of Mississippi Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00849810 is a NA study that was terminated before completion, run by University of Mississippi Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT00849810, a NA study, was terminated before completion, sponsored by University of Mississippi Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the effects of nebivolol and metoprolol on 24-hour ambulatory blood pressure characteristics and basal metabolic rates in patients with hypertension.
Interventions
- DRUG Nebivolol
- DRUG Metoprolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849810
The ClinicalTrials.gov registry entry for NCT00849810 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nebivolol is the first listed.
NCT00849810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00849810 about?
NCT00849810 is a clinical study titled "Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate". The purpose of the study is to compare the effects of nebivolol and metoprolol on 24-hour ambulatory blood pressure characteristics and basal metabolic rates in patients with hypertension.
What is the current status of trial NCT00849810?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2009-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00849810?
The interventions under investigation include: Nebivolol (DRUG), Metoprolol (DRUG).
Who is sponsoring clinical trial NCT00849810?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.